United Therapeutics UTHR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's accounts payable?
- United Therapeutics (UTHR) reported accounts payable of $498.3M in Q1 2026.
- How has United Therapeutics's accounts payable changed year-over-year?
- United Therapeutics's accounts payable increased by 35.8% year-over-year, from $367M to $498.3M.
- What is the long-term trend for United Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), United Therapeutics's accounts payable has grown at a 21.1% compound annual growth rate (CAGR), from $187M to $488M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.